Related Experiment Video
Updated: Jun 24, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent
Jayashri Srinivasan1, H Royden Jones
1Department of Neurology, Lahey Clinic, 41 Mall Road, Burlington, Massachusetts 01805, United States. jayashri_srinivasan@lahey.org
Abstract:
Paclitaxel is a microtubule-stabilizing chemotherapeutic agent used in ovarian and breast cancer; its principal adverse effect is sensory neuropathy. We describe the occurrence of sensory polyneuropathy after multiple paclitaxel-eluting stents in a patient who may have sub-clinical Sjogrens syndrome.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetic Neuropathy